EU grants Anticalin Therapeutic development fund to Eurocalin Consortium
Anticalins are novel, next generation therapeutic proteins designed to bind and antagonize a wide spectrum of ligands. They derived from human lipocalins, designed to solve the pharmacological and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.